Practice closure for staff training 24/04/25 from 12:30pm
On Thursday 24 April 2025, our practice will be closed from 12:30pm for essential stafftraining. For more information please read…
Providing patient-focused, professional healthcare
A guide to conditions, symptoms and treatments, including what to do and when to get help.
We are currently accepting new NHS patients, find out about registering with the surgery.
Our aim is to provide a high standard of medical care in a friendly and professional manner. We strive to be a caring practice that looks after the community whilst balancing the needs of our patients and staff. We feel that a successful practice is one that evolves, reflects and embraces change and where staff are happy at work.
Find out how to make, change or cancel an appointment
Get a repeat prescription, find a pharmacy or ask a prescription question
Get a sick (fit) note for work or find out about self-certification
Get your recent test results and find out what to do next
Find out how to register and if you live in our catchment area
Find out how to contact the surgery and what to do when we are closed
Local and national help and advice for you to get the support you need for your wellbeing
Take part in the NHS Friends and Family Test and provide feedback
See the latest updates from our Patient Participation Group and how you can join them
Secure access 24 hours a day. Access a range of NHS services anytime, anywhere.
Find the service and help you need.
High Dose Oestrogen HRT Regimes Guideline Update
I am writing to you to share some information on recent changes to HRT guidelines. The British
Menopause Society (BMS) have recently updated their recommendations for progesterone
dosage in women using higher doses of oestrogen as part of their HRT. High dose oestrogen is
defined as:
As you may recall from when you started HRT, whenever we give oestrogen to women with a
uterus (womb) it is very important that we give them progesterone alongside it. If we were to give
oestrogen without progesterone the lining of the womb (endometrium) can thicken and over
time this can lead to endometrial cancer. The progesterone protects the endometrium from this
risk. Signs that would prompt us to consider investigations for endometrial cancer would be any
bleeding that occurs over 12 months after your periods have stopped or a change in your
bleeding pattern if you periods haven’t stopped (more frequent, heavier, or prolonged bleeding).
As you may also remember the reason that we tend to use Utrogestan (also known as
micronised progesterone) for the progesterone component is that the data suggests this carries
very little or no increased risk in breast cancer.
The new BMS guidelines state:
“There are insufficient data to advise on endometrial cancer risk when micronised
progesterone, at a dose used for low or standard dose Oestrogen, is used in combination with
moderate or high dose Oestrogen. Until evidence relating to safety with moderate and high dose
Oestrogen is available, a pragmatic approach needs to be considered, as the risk to breast
tissue from increasing the progesterone dose is also unknown; the use of 200 mg as a
continuous preparation [this means if you are taking it daily] and 300 mg as a sequential
preparation [this means if you are taking it for 2 weeks out of every 4] should be offered if using
high dose Oestrogen”.
In view of these new guidelines, you have four options going forward:
Please contact the practice if you would like to discuss any of this further
Dr Heather Craigie
GP Partner and Menopause Lead
On Thursday 24 April 2025, our practice will be closed from 12:30pm for essential stafftraining. For more information please read…
Our popular, handy reference guide – ‘Primary Care: Get To Know Where To Go’ – is back! This publication tells…